Showing results (171-180 of 250) with videos related to
Sort By:
Pageof 25
BMC Cancer|January 14, 2022
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I studyLauren R Schaff, Mina Lobbous, Dean Carlow, et al.Stroke|September 13, 2019
Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression ProfileBabak B Navi, Ryna Mathias, Carla P Sherman, et al.World Journal of Otorhinolaryngology - Head and Neck Surgery|December 7, 2022
Integration of an enhanced recovery after surgery program for patients undergoing pituitary surgeryStephanie Flukes, Ilya Laufer, Jennifer Cracchiolo, et al.Neuro-Oncology|May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working GroupNils D Arvold, Terri S Armstrong, Katherine E Warren, et al.Cancer Research|May 18, 2018
Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor PatientsVesselin Z Miloushev, Kristin L Granlund, Rostislav Boltyanskiy, et al.Neuro-Oncology|December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant gliomaAntonio Omuro, Timothy A Chan, Lauren E Abrey, et al.Journal of Neuro-Oncology|December 12, 2019
Characterization of MGMT and EGFR protein expression in glioblastoma and association with survivalLauren R Schaff, Dongyao Yan, Sheeno Thyparambil, et al.The Journal of Clinical Endocrinology and Metabolism|October 30, 2025
Prospective Assessment of Mood and Quality of Life in Cushing syndrome before and after Biochemical ControlAngeliki Theodorou, Emily C Tan, Mohammed A Bakkar, et al.Neurosurgery|May 11, 2022
Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case ReportSanjit Shah, Saima Manzoor, Yehudit Rothman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium studyJohn F de Groot, Kathleen R Lamborn, Susan M Chang, et al.Pageof 25